Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)
| CAPS Rating |
|
|---|
AEGR
VS S&P 500 (SPY)
AEGR News and Commentary
- This Just In: Upgrades and Downgrades – The Motley Fool
- Wall Street Experts: Deutsche Bank Loves These Stocks Boosted by Insider Buying – NASDAQ
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – NASDAQ
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – The Motley Fool
- IPO Market: All eyes on the Groupon IPO – NASDAQ
- IPO Stocks: Here's a List of IPO Stocks With Insider Buying – The Motley Fool
- IPO Stocks: Here's a List of IPO Stocks With Insider Buying – NASDAQ
- 7 Stocks With CEO Buys of At Least $96,000 in the Past Week – SeekingAlpha
- JP Morgan's Extremely Bullish New Stock Picks – SeekingAlpha
How do you think AEGR will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
14
Outperform
1
Underperform
All-Star Players
3
Outperform
0
Underperform
Wall Street
4
Outperform
0
Underperform
RSS Headlines
Fool UK
